يعرض 1 - 10 نتائج من 52 نتيجة بحث عن '"MESH: Receptors, Immunologic"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1

    المؤلفون: A. Del Bello, Nassim Kamar, E Treiner

    المساهمون: Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Département de Néphrologie et Transplantation d'organes, Hôpital de Rangueil, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], CHU Toulouse [Toulouse]

    المصدر: Clinical and Experimental Immunology
    Clinical and Experimental Immunology, Wiley, 2020, 200 (1), pp.89-104. ⟨10.1111/cei.13412⟩
    Clin Exp Immunol

    مصطلحات موضوعية: Male, 0301 basic medicine, T-Lymphocytes, MESH: ABO Blood-Group System / immunology, medicine.medical_treatment, Receptor expression, Programmed Cell Death 1 Receptor, MESH: HLA Antigens / genetics, MESH: Blood Group Incompatibility / immunology, MESH: Histocompatibility / immunology, MESH: Programmed Cell Death 1 Receptor / genetics, donor-specific antibodies, MESH: Lymphocyte Depletion / methods, 0302 clinical medicine, HLA Antigens, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Living Donors, Immunology and Allergy, Receptors, Immunologic, immune exhaustion, MESH: T-Lymphocytes / immunology, MESH: Living Donors, MESH: Aged, MESH: Middle Aged, MESH: HLA Antigens / metabolism, MESH: Receptors, Immunologic / immunology, Graft Survival, Middle Aged, MESH: Graft Survival / immunology, MESH: ABO Blood-Group System / genetics, Cytokine, medicine.anatomical_structure, Blood Group Incompatibility, Histocompatibility, Female, graft rejection, MESH: Signaling Lymphocytic Activation Molecule Family / immunology, MESH: Histocompatibility / genetics, MESH: T-Lymphocytes / metabolism, Adult, T cell, Immunology, T cells, MESH: Graft Survival / genetics, MESH: Programmed Cell Death 1 Receptor / immunology, MESH: Receptors, Immunologic / metabolism, Human leukocyte antigen, Biology, Lymphocyte Depletion, MESH: Kidney Transplantation / methods, ABO Blood-Group System, MESH: Programmed Cell Death 1 Receptor / metabolism, 03 medical and health sciences, MESH: Cross-Sectional Studies, Immune system, TIGIT, Signaling Lymphocytic Activation Molecule Family, medicine, Humans, ABO-incompatible transplantation, Aged, MESH: Receptors, Immunologic / genetics, MESH: Gene Expression Profiling / methods, MESH: Humans, MESH: Blood Group Incompatibility / genetics, Gene Expression Profiling, MESH: Signaling Lymphocytic Activation Molecule Family / metabolism, MESH: Adult, Original Articles, Kidney Transplantation, cytokines, MESH: Male, Transplantation, Cross-Sectional Studies, inhibitory receptors, 030104 developmental biology, MESH: HLA Antigens / immunology, MESH: Signaling Lymphocytic Activation Molecule Family / genetics, MESH: Female, transplantation, 030215 immunology

  2. 2

    المساهمون: Biologie des Bactéries intracellulaires - Biology of Intracellular Bacteria, Université Paris Cité (UPCité)-Microbiologie Intégrative et Moléculaire (UMR6047), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Paris Cité (UPCité), Matière et Systèmes Complexes (MSC), Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Plateforme BioImagerie Ultrastructurale – Ultrastructural BioImaging Platform (UTechS UBI), Institut Pasteur [Paris] (IP), Work in the C.B. laboratory was financed by the grant n° ANR-20-CE15-0021-01-BIOEV, the Institut Pasteur, the Fondation pour la Recherche Médicale (FRM) grant N° EQU201903007847 and the grant n°ANR-10-LABX-62-IBEID. For electron microscopy experiments M. Nilges and the Equipex CACSICE (n° ANR-11-EQPX-0008) provided funding for the Falcon II direct detector. G.L. lab is funded by ANR-20-CE15-0021-02, ANR-19-CE18-0020-03, and ANR-18-IDEX-0001, IdEx Université de Paris. S.B. is a recipient of a PhD fellowship from PSL University. The funders, other than the authors, did not play any role in the study or in the preparation of the article or decision to publish., We thank Monica Rolando for critically reading of the manuscript and helpful discussions and Nathalie Aulner and Anne Danckaert, Photonic BioImaging (PBI) UTechS for support., T.S., P.E., S.B., and G.L. performed the experiments, C.R. performed the bioinformatics analyses, GPA performed the electron and cryoTEM experiments, T.S., P.E., and C.B. designed the experiments, T.S. and C.B. wrote the article, C.B. supervised the work and acquired funds., ANR-20-CE15-0021,BioEV,Biogenèse, trafic et rôles des vésicules extracllulaires de Legionella pneumophila au cours de l'infection(2020), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-11-EQPX-0008,CACSICE,Centre d'analyse de systèmes complexes dans les environnements complexes(2011), ANR-19-CE18-0020,EXCELLDISC,Vésicules Extracellulaires et thérapie du disque intervertébral(2019), ANR-18-IDEX-0001,Université de Paris,Université de Paris(2018)

    المصدر: Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
    Nature Communications
    Nature Communications, 2022, 13 (1), pp.762. ⟨10.1038/s41467-022-28454-x⟩

  3. 3

    المساهمون: Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de pharmacologie et de biologie structurale (IPBS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Centre de biologie du développement (CBD), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Centre de Biologie Intégrative (CBI), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Imperial College London, laffont-pradines, sophie, Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, CNRS, INSERM, UPS, Toulouse, France. (Infinity), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Université Fédérale Toulouse Midi-Pyrénées

    المصدر: Journal of Allergy and Clinical Immunology
    Journal of Allergy and Clinical Immunology, 2022, 149 (1), pp.237-251.e12. ⟨10.1016/j.jaci.2021.04.029⟩
    Journal of Allergy and Clinical Immunology, Elsevier, 2021, ⟨10.1016/j.jaci.2021.04.029⟩

    وصف الملف: application/pdf

  4. 4

    المساهمون: William Harvey Research Institute, Barts and the London Medical School, Division of Cancer Studies, Immunologie et Pathologie (EA2216), Université de Brest (UBO)-IFR148, Laboratoire d'Immunologie et Immunothérapie, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre for Rheumatology - London

    المصدر: International Reviews of Immunology
    International Reviews of Immunology, Informa Healthcare, 2013, 32 (4), pp.428-44. ⟨10.3109/08830185.2013.788648⟩

  5. 5

    المساهمون: Division of Structural Biology, Kyushu University [Fukuoka]-Medical Institute of Bioregulation, Department of Biomolecular Engineering, Graduate School of Engineering-Tohoku University [Sendai], Structural Biology Center, National Institute of Genetics (NIG), Department of Pathology and Immunology, Washington University School of Medicine, Nuffield Department of Clinical Medicine [Oxford], University of Oxford [Oxford], Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS), Cancer Research UK Receptor Structure Group, Wellcome Trust Centre for Human Genetics, Sir William Dunn School of Pathology [Oxford], Ministry of Education, Sports, Culture, and Technology of Japan, the 2000th year Joint Research Project of Sokendai, Nakajima Foundation, Cancer Research UK, Medical Research Council

    المصدر: Proceedings of the National Academy of Sciences of the United States of America
    Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100 (15), pp.8856-61. ⟨10.1073/pnas.1431057100⟩

    مصطلحات موضوعية: Models, Molecular, Protein Conformation, MESH: Sequence Homology, Amino Acid, MESH: Membrane Glycoproteins, Leukocyte Immunoglobulin-like Receptor B1, MESH: Amino Acid Sequence, Protein tyrosine phosphatase, CD8-Positive T-Lymphocytes, MESH: Base Sequence, Leukocyte immunoglobulin-like receptors, MESH: Histocompatibility Antigens Class I, MESH: Recombinant Proteins, MESH: Protein Conformation, 0302 clinical medicine, HLA Antigens, HLA-G, Immunoreceptor tyrosine-based activation motif, Receptors, Immunologic, MESH: Antigens, CD, MESH: HLA Antigens, 0303 health sciences, Membrane Glycoproteins, Multidisciplinary, MESH: Kinetics, biology, Biological Sciences, MESH: CD8-Positive T-Lymphocytes, Recombinant Proteins, MESH: Surface Plasmon Resonance, Cell biology, Killer Cells, Natural, [SDV.IMM]Life Sciences [q-bio]/Immunology, Immunoreceptor tyrosine-based inhibitory motif, MESH: Models, Molecular, MESH: Killer Cells, Natural, DNA, Complementary, CD8 Antigens, Molecular Sequence Data, MESH: Binding, Competitive, In Vitro Techniques, Binding, Competitive, 03 medical and health sciences, Antigens, CD, Cell surface receptor, MHC class I, Humans, Amino Acid Sequence, MESH: Receptors, Immunologic, 030304 developmental biology, HLA-G Antigens, Binding Sites, MESH: Humans, MESH: Molecular Sequence Data, Base Sequence, Sequence Homology, Amino Acid, Histocompatibility Antigens Class I, MESH: DNA, Complementary, Surface Plasmon Resonance, Molecular biology, Kinetics, MESH: Binding Sites, biology.protein, MESH: Antigens, CD8, 030215 immunology

  6. 6

    المساهمون: Génétique du Développement humain - Human developmental genetics, Institut Pasteur [Paris] (IP), Fondation Ophtalmologique Adolphe de Rothschild [Paris], Université Paris Descartes - Paris 5 (UPD5), This work was supported by Laboratoire Lilly France, EuroDSD in the European Community’s Seventh Framework Programme FP7/2007–2013 under Grant 201444 (to K.M. and A.B.) and Projet Blanc Institut Pasteur/Assistance Publique-Hôpitaux de Paris 2011 under Grant 295097 (to K.M. and R.B.)., European Project: 201444,EC:FP7:HEALTH,FP7-HEALTH-2007-A,EURODSD(2008)

    المصدر: Journal of Clinical Endocrinology and Metabolism
    Journal of Clinical Endocrinology and Metabolism, 2017, 102 (7), pp.2401-2406. ⟨10.1210/jc.2016-1095⟩

  7. 7

    المساهمون: Génomique virale et vaccination, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Transcriptome et Epigénome (PF2), Institut Pasteur [Paris], Interactions hôtes-agents pathogènes [Toulouse] (IHAP), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Cyclotron Réunion Océan Indien (CYROI), Université de La Réunion (UR)-Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), Fondation pour la Recherche Médicale : FDT20140931129Agence Nationale de Recherches sur le Sida et les Hepatites Virales : CSS1-AO 2012-2Agence Nationale de Recherches sur le Sida et les Hepatites Virales : CSS1-AO 2012-1, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Université de Toulouse (UT), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)

    المصدر: eLife
    eLife, eLife Sciences Publication, 2016, 5, pp.e11275. ⟨10.7554/eLife.11275⟩
    eLife, 2016, 5, pp.e11275. ⟨10.7554/eLife.11275⟩
    eLife, Vol 5 (2016)

  8. 8

    المساهمون: Service de Réanimation Médicale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Faculté de Médecine [Nancy], Université de Lorraine (UL), INOTREM SA, Université de Lorraine (UL)-Université de Lorraine (UL)

    المصدر: Pharmacological Research
    Pharmacological Research, Elsevier, 2015, 100, pp.261-265. ⟨10.1016/j.phrs.2015.07.027⟩

  9. 9

    المساهمون: Centre d'Immunologie de Marseille - Luminy (CIML), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Chirurgie, Assistance Publique - Hôpitaux de Marseille (APHM)-Hospices Civiles de Marseille-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Cancer Research Laboratory [Berkeley] (CRI), University of California [Berkeley], University of California-University of California, Dipartimento di Medicina Sperimentale, Universita degli studi di Genova, Comprehensive Cancer Center, Ohio State University [Columbus] (OSU), Immunologie des tumeurs et immunothérapie (UMR 1015), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique en Biotherapie des cancers (CIC 1428 , CBT 507 ), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), School of Medicine, Université Paris-Sud - Paris 11 (UP11), University of California SF (UNIVERSITY OF CALIFORNIA), University of California, Howard Hughes Medical Institute [Chevy Chase] (HHMI), Howard Hughes Medical Institute (HHMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11), University of California [Berkeley] (UC Berkeley), University of California (UC)-University of California (UC), Università degli studi di Genova = University of Genoa (UniGe), Institut Gustave Roussy (IGR)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), University of California (UC)

    المصدر: Science
    Science, American Association for the Advancement of Science, 2011, 331 (6013), pp.44-9. ⟨10.1126/science.1198687⟩
    Science, 2011, 331 (6013), pp.44-9. ⟨10.1126/science.1198687⟩
    Science; Vol 331

  10. 10

    المساهمون: Laboratory of experimental immunology, Frederick National Laboratory for Cancer Research (FNLCR), Centre d'Immunologie de Marseille - Luminy (CIML), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Service de Chirurgie, Assistance Publique - Hôpitaux de Marseille (APHM)-Hospices Civiles de Marseille-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Blood
    Blood, American Society of Hematology, 2008, 111 (7), pp.3571-8. ⟨10.1182/blood-2007-07-100057⟩
    Blood, 2008, 111 (7), pp.3571-8. ⟨10.1182/blood-2007-07-100057⟩